tr?id=&ev=PageView&noscript=

Texas News You Can Use

HTX News You Can Use

Dallas-Fort Worth News You Can Use

San Antonio​ Worth News You Can Use

  • All Tags

Republican vice presidential candidate Sen. JD Vance, R-Ohio, attends a campaign event in Glendale, Ariz., Wednesday, July 31, 2024. (AP Photo/Jae C. Hong)

JD Vance says he wants to help families, but missed vote to expand child tax credit

| | | | |
Republican vice presidential candidate JD Vance proposed more than doubling the federal child tax credit to $5,000 over the weekend, but recently missed the chance to vote for an expanded credit—an effort his fellow Senate Republicans blocked.
national politics - Courier Texas

“Vibe shift”: Young Texas voters, motivated by Kamala Harris, lock into the presidential election

| | | | |
These first-time, Texas voters are finally motivated by the election now that Kamala Harris is in the race.
Kyleigh Thurman inside her home in Burnet County, Texas.

Dozens of pregnant women, some bleeding or in labor, being turned away from ERs despite federal law

| | | | | | | |
Even as the Biden administration publicly warned hospitals to treat pregnant patients in emergencies, facilities continue to violate the federal law. The issue became a focus for the administration following reports of women being improperly treated in emergency rooms after the Supreme Court’s decision to overturn the constitutional right to an abortion more than two years ago.
Tim Walz and JD Vance.

Vice president candidates present stark contrast on voting issues

| |
Vice president candidates present stark contrast on voting issues. Here's what you need to know about Tim Walz and JD Vance.
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee. (Photo by Kayla Bartkowski/The Boston Globe via Getty Images)

Major drugmakers capped cost of asthma inhalers at $35 per month after investigation from Democrats

| | | |
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee.
BLOCKED
BLOCKED